Showing results (281-290 of 339) with videos related to
Sort By:
Pageof 34
Diabetes, Obesity & Metabolism|November 2, 2021
Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or strokeGoh Eun Chung, Eun Ju Cho, Jeong-Ju Yoo, et al.The Korean Journal of Internal Medicine|April 6, 2016
Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosisSu Jong Yu, Jung-Hwan Yoon, Won Kim, et al.Clinical and Molecular Hepatology|November 25, 2025
Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysisJuhee Ahn, Moon Haeng Hur, Hyunjae Shin, et al.Gut and Liver|October 24, 2019
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter StudyMi Young Jeon, Beom Kyung Kim, Jun Yong Park, et al.Clinical and Molecular Hepatology|May 29, 2020
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatmentCheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, et al.Canadian Journal of Gastroenterology & Hepatology|September 24, 2024
The Predictive Value of Time-Varying Noninvasive Scores on Long-Term Prognosis of NAFLD in South KoreaSung Won Chung, Min Kyung Park, Xiao Zhang, et al.Cancer Gene Therapy|August 7, 2021
Systems analysis identifies endothelin 1 axis blockade for enhancing the anti-tumor effect of multikinase inhibitorChae Young Hwang, Su Jong Yu, Jae-Kyung Won, et al.Digestive Diseases and Sciences|November 27, 2012
The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovirYuri Cho, Dong Hyeon Lee, Kwang Hyun Chung, et al.BMC Gastroenterology|March 26, 2022
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysisNa Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, et al.Cancers|July 10, 2020
Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for SurveillanceJun Sik Yoon, Dong Ho Lee, Eun Ju Cho, et al.Pageof 34